Skip to content
Catalyst

metforminPapers

Papers about metformin

papers
3,985
41 years, by papers

Newest first

3,701 to 3,750 of 3,985

Every paper here, unless its row says otherwiseIndexed under metformin in PubMed's chemical list; returned by a PubMed search for metformin

  • Long-term effects on lipids and lipoproteins of pioglitazone versus gliclazide addition to metformin and pioglitazone versus metformin addition to sulphonylurea in the treatment of type 2 diabetes.

    Diabetologia2005PMID 16283239

  • Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.

    Clinical therapeutics2005PMID 16291411

  • The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.

    Science (New York, N.Y.)2005PMID 16308421

  • Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?

    European journal of obstetrics, gynecology, and reproductive biology2005PMID 16316811

  • Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.

    Clinical therapeutics2005PMID 16330290

  • Rosiglitazone/metformin fixed-dose combination compared with uptitrated metformin alone in type 2 diabetes mellitus: a 24-week, multicenter, randomized, double-blind, parallel-group study.

    Clinical therapeutics2005PMID 16330291

  • Investigation of the pharmacokinetic and pharmacodynamic interactions between memantine and glyburide/metformin in healthy young subjects: a single-center, multiple-dose, open-label study.

    Clinical therapeutics2005PMID 16330295

  • The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome.

    Gynecological endocrinology2005PMID 16335907

  • Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome.

    Clinical endocrinology2005PMID 16343096

  • Effects of rosiglitazone added to submaximal doses of metformin compared with dose escalation of metformin in type 2 diabetes: the EMPIRE Study.

    Current medical research and opinion2005PMID 16368054

  • The effect of metformin treatment to ovarian response in cases with PCOS.

    Archives of gynecology and obstetrics2004PMID 12764624

  • Favorable effects of pioglitazone and metformin compared with gliclazide on lipoprotein subfractions in overweight patients with early type 2 diabetes.

    Diabetes care2004PMID 14693964

  • One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes.

    Diabetes care2004PMID 14693980

  • Metformin therapy increases insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome.

    The Journal of clinical endocrinology and metabolism2004PMID 14715857

  • Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome.

    Clinical endocrinology2004PMID 14725687

  • Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.

    Fertility and sterility2004PMID 14967373

  • Dexamethasone reduces androgen levels in metformin-treated patients with polycystic ovary syndrome.

    Fertility and sterility2004PMID 14967392

  • Glycemic control with glyburide/metformin tablets in combination with rosiglitazone in patients with type 2 diabetes: a randomized, double-blind trial.

    The American journal of medicine2004PMID 14969649

  • Addition of pioglitazone or bedtime insulin to maximal doses of sulfonylurea and metformin in type 2 diabetes patients with poor glucose control: a prospective, randomized trial.

    The American journal of medicine2004PMID 14969650

  • Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome.

    Hormone and metabolic research2004PMID 14983408

  • Comparison of pioglitazone and metformin efficacy using homeostasis model assessment.

    Diabetic medicine2004PMID 14984448

  • Metformin in the treatment of patients with non-alcoholic steatohepatitis.

    Alimentary pharmacology & therapeutics2004PMID 14987322

  • Six-month treatment with low-dose dexamethasone further reduces androgen levels in PCOS women treated with diet and lifestyle advice, and metformin.

    Human reproduction (Oxford, England)2004PMID 14998946

  • Blood pressure and cardiac autonomic nervous system in obese type 2 diabetic patients: effect of metformin administration.

    American journal of hypertension2004PMID 15001195

  • The effects of metformin on insulin resistance, clomiphene-induced ovulation and pregnancy rates in women with polycystic ovary syndrome.

    European journal of obstetrics, gynecology, and reproductive biology2004PMID 15063963

  • Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.

    The Journal of clinical endocrinology and metabolism2004PMID 15070917

  • Effects of exercise training and metformin on body composition and cardiovascular indices in HIV-infected patients.

    AIDS (London, England)2004PMID 15090799

  • Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study.

    Human reproduction (Oxford, England)2004PMID 15117902

  • Differential effects of metformin and exercise on muscle adiposity and metabolic indices in human immunodeficiency virus-infected patients.

    The Journal of clinical endocrinology and metabolism2004PMID 15126538

  • Pioglitazone as monotherapy or in combination with sulfonylurea or metformin enhances insulin sensitivity (HOMA-S or QUICKI) in patients with type 2 diabetes.

    Current medical research and opinion2004PMID 15140339

  • Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes.

    Diabetes care2004PMID 15161787

  • Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study.

    Human reproduction (Oxford, England)2004PMID 15178665

  • Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study.

    The Journal of clinical endocrinology and metabolism2004PMID 15181054Indexed under metformin in PubMed's chemical list

  • The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review.

    Journal of internal medicine2004PMID 15189360

  • Biowaiver extension potential to BCS Class III high solubility-low permeability drugs: bridging evidence for metformin immediate-release tablet.

    European journal of pharmaceutical sciences2004PMID 15196586

  • Efficacy and tolerability of initial combination therapy with nateglinide and metformin in treatment-naïve patients with type 2 diabetes.

    Current medical research and opinion2004PMID 15200747

  • Comparison of the effect of orlistat vs orlistat plus metformin on weight loss and insulin resistance in obese women.

    International journal of obesity and related metabolic disorders2004PMID 15211369

  • Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity.

    Human reproduction (Oxford, England)2004PMID 15229206

  • Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes.

    Diabetes2004PMID 15277403

  • The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: a placebo-controlled, randomized clinical trial.

    The Journal of clinical endocrinology and metabolism2004PMID 15292331

  • A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.

    Fertility and sterility2004PMID 15302293

  • Pharmacokinetics and dose proportionality of extended-release metformin following administration of 1000, 1500, 2000 and 2500 mg in healthy volunteers.

    Biopharmaceutics & drug disposition2004PMID 15334625

  • Metabolic variations with oral antidiabetic drugs in patients with Type 2 diabetes: comparison between glimepiride and metformin.

    Diabetes, nutrition & metabolism2004PMID 15334791

  • Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment.

    The Journal of clinical endocrinology and metabolism2004PMID 15356029

  • Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide.

    The Journal of clinical endocrinology and metabolism2004PMID 15356085

  • Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial.

    The Journal of clinical endocrinology and metabolism2004PMID 15472166

  • Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity.

    Fertility and sterility2004PMID 15482765

  • Pre-prandial vs. post-prandial capillary glucose measurements as targets for repaglinide dose titration in people with diet-treated or metformin-treated Type 2 diabetes: a randomized controlled clinical trial.

    Diabetic medicine2004PMID 15498086

  • Effects of metformin treatment on luteal phase progesterone concentration in polycystic ovary syndrome.

    Brazilian journal of medical and biological research2004PMID 15517078

  • Effect of metformin vs. placebo treatment on serum fatty acids in non-diabetic obese insulin resistant individuals.

    Prostaglandins, leukotrienes, and essential fatty acids2004PMID 15519498

The next 50 papers

← Previous 50